Bora Pharmaceuticals

As a full-service global #CDMO, Bora Pharmaceuticals specializes in the development and manufacturing of a wide range of dosage forms including OSD, semi-solid, liquid, ophthalmic, and sterile injectable products for clinical and commercial use. Powered by our unique culture and the strength of our people, Bora is committed to delivering high quality products to our customers and the patients they serve. Find out how Bora's specialized expertise, expansive global network, and highly-skilled teams can help make your success more certain➡️ https://bit.ly/3EivWNm

What a way to kick-start spring with a special bike donation from our partners at Bora Pharmaceuticals for the kids across our BGC Peel Club. #OpportunityChangesEverything www.bgcpeel.org

Last week, Bora Pharmaceuticals participated in the Biotech Job Fair & Networking Event at Montgomery College. We appreciated the opportunity to share our mission, connect with talented professionals, and support those impacted by recent changes in government research roles. Thank you to the organizers for creating such a meaningful and well-rounded event, and thank you to Vera Biles and Nick Droste for representing Bora. #Biotech #STEMCareers #MontgomeryCollege

Join us TODAY for Fierce Biotech's Virtual Event: "Advancing Complex Biologics into Real Treatments: Technologies, Experts and Partners to Know in 2025." Tune in at 12:15 pm EDT to hear from Bora Biologics CEO Steve Lam and Bora Pharmaceuticals CDMO Division President J.D. Mowery as they discuss a new model for reliable global biologics supply and share their insights on the challenges, opportunities, and advancements in biologics development and manufacturing. Register now ➡️ https://bit.ly/4iekv7l #Biologics #BiotechPartnerships #CDMO

We were honored to have recently hosted a delegation from the Stanford University Graduate School of Business, led by Yu Ding, as part of their Global Study Trip focused on healthcare in Asia — with Singapore and Taiwan as key destinations. During the visit, our CEO Bobby Sheng shared insights on the key drivers behind Bora Pharmaceuticals’ rapid growth — from our world-class manufacturing capabilities to our unique "Glocal" service mindset that sets us apart as a leading and transformative CDMO. The group also toured our Zhunan manufacturing site, where they got a firsthand look at our advanced operations in specialized oral solid dosage (OSD) delivery systems. Thank you Stanford GSB for the engaging exchange!

Join us next Wednesday, April 9th for Fierce Biotech's Virtual Event: "Advancing Complex Biologics into Real Treatments: Technologies, Experts and Partners to Know in 2025." Hear from Bora Biologics CEO Steve Lam and Bora Pharmaceuticals CDMO Division President J.D. Mowery as they discuss a new model for reliable global biologics supply and share their insights on the challenges, opportunities, and advancements in biologics development and manufacturing. Register for the event today: https://bit.ly/42DloAH 📅 Wednesday, April 9, 2025 🕦 11:50am – 12:10pm EDT #Biologics #BiotechPartnerships #CDMO

Heading to CPHI Japan in Tokyo next week? SoonKyu(Austin) Shin, Director, Business Development will be in attendance and is looking forward to connecting with the global pharma community to discuss how Bora's comprehensive CDMO solutions and expansive network can help bring your products to market. Schedule a meeting ➡️https://bit.ly/4iQlz2r

It's time to start planning for the largest and most comprehensive biotechnology event of the year, ✨ BIO International Convention✨ The Bora Group is excited to be heading to Boston, June 16 - 19, to connect with biopharma innovators and discuss the latest cutting-edge breakthroughs, advancements, and trends in biologics development and manufacturing. ✅ Learn how Bora Biologics' specialized expertise, enhanced capabilities, and latest strategic investments can help accelerate your product to commercial success. ✅Explore our end-to-end solutions, including Bora's sterile fill/finish capabilities at our cGMP facility in Baltimore, MD, USA. ✅ Discover a partnership dedicated to quality, innovation, and customer satisfaction. Arrange a meeting with us ➡️ https://bit.ly/4c7D8s1 #BIO2025 #CDMO

Facility Spotlight: 📍Maple Grove, MN, USA This state-of-the-art facility is designed to deliver exceptional quality and reliability at every step of the drug development process for a broad range of dosage forms, including oral solids, powders, and liquids ⤵️ 🏭 Key Facility Highlights: 🔸 270,000 sq feet of manufacturing space 🔸 Robust quality control labs and a dedicated R&D team to support product and analytical development 🔸 Extensive experience in complex OSD development and manufacturing 🔸 US FDA and DEA approved to develop and commercialize a broad range of dosage forms including: oral solids, powders, and liquids Discover how Bora's team, technologies, and expertise can help advance your product to market: https://bit.ly/4hNtPih #OSD #CDMO #SmallMolecules

That's a wrap on another successful #DCATWeek. The Bora team had an engaging and productive four days connecting with new customers, strengthening existing partnerships, and networking with industry peers. We also had the opportunity to present at the Member Company Announcement Forum where we unveiled our plans to integrate AI across the infrastructure of Bora to revolutionize efficiency and patient-centric operations. A special thank you to all those who joined us for our customer reception on Tuesday evening at Nubeluz in NYC. It was the perfect atmosphere and opportunity to express our appreciation to our valued customers, partners, and colleagues for their continued collaboration and support. If we missed you this week, schedule another time to meet with us and be sure to catch us at #BIOInternational in June ➡️https://bit.ly/4hvHH0t